Hormone Therapy Tied to Increased Migraine Frequency

Postmenopausal women on hormone therapy report more frequent and longer-lasting migraine episodes.

Updated on Oct. 28, 2026 in Women’s Health

Gouache-painted illustration of an hourglass containing abstract pulsing light filaments, representing the link between hormonal therapy and neurological activity.
New research from Weill Cornell Medicine indicates that estrogen-based hormone therapy for postmenopausal women is linked to more frequent and prolonged migraine episodes. AI Illustration. Upload story photo >

Live Poll

Do you feel the benefits of hormone therapy justify the potential for increased migraine frequency?

New research suggests a link between postmenopausal hormone therapy and an uptick in migraine activity. Patients on this therapy experience migraines more often and for longer durations than those who do not use it.

Why it matters

Estrogen is a known migraine trigger, and the intersection of hormone replacement and menopausal symptoms like hot flashes can further complicate neurological health. Understanding this connection helps women and their doctors better manage treatment plans during menopause.

Participants using hormone therapy reported a 1.16 times increase in monthly migraine frequency and a 0.95-day increase in average duration per episode. No significant differences were observed in migraine severity or analgesic medication usage.

The players

Weill Cornell Medicine

This is a medical research institution affiliated with the researchers who conducted the study on hormone therapy and migraines.

The details

The research, associated with Weill Cornell Medicine, indicates that estrogen may act as a catalyst for headaches in postmenopausal women. While frequency and duration rose, the study did not find that patients required more pain relief medication, nor were the headaches more severe in nature.

Timeline

  1. October 2026: Findings regarding hormone therapy and migraines were released.

Health Landscape

This study updates the historical understanding of estrogen as a migraine trigger by specifically quantifying the impact of hormone therapy in postmenopausal women. It adds to the medical landscape by highlighting how menopausal symptoms and neurological triggers often exacerbate one another.

Women currently using or considering hormone therapy should discuss potential headache side effects with their healthcare providers to balance symptom management. This data may prompt patients to monitor the timing and frequency of their headaches more closely to identify potential triggers.

The takeaway

Patients should track their migraine symptoms alongside hormone therapy use to determine if adjustments are necessary. Consulting a specialist is essential for women experiencing a noticeable shift in headache patterns during menopause.

Further reading

For more context on how various health treatments affect neurological wellness, explore our Women’s Health section.

Source note: This article includes information reported by Medicalnewstoday.

Live Poll

Do you feel the benefits of hormone therapy justify the potential for increased migraine frequency?